Making it easier to access clinical trial data: Vivli launches its new data sharing platform in beta-form

Making it easier to access clinical trial data: Vivli launches its new data sharing platform in beta-form

Vivli is a non-profit organization establishing a global data-sharing and analytics platform to serve all elements of the international research community.

It’s launched its public test site, a new clinical research data sharing platform, and now invites collaborators across Cochrane’s community to try it out and tell them what they think!

You can access the app at https://app.vivli.org and learn more about the Vivli organization itself and access resources of how to use the platform at http://vivli.org

Vivli offers users a novel way to search, aggregate, and analyze data from clinical trials. In the public beta, users can explore the search functionality of the Vivli platform, exploring more than 600 clinical trials listed on the beta site. Once the platform launches in mid-July, researchers can search for studies and request anonymized individual patient data (IPD) from these studies to analyze in a secure environment and store their results (with a minted DOI to help meet ICJME requirements). All this functionality will be available from full launch on July 19 2018.

 “Vivli’s intuitive search interface allows users to refine their search and only request the studies that they need to answer important research questions,” said Dr. Ida Sim, Vivli’s Technical Lead. “This will hopefully accelerate the research process to drive forward scientific discovery.”

Vivli’s Director of Strategy and Operations, Julie Wood said: “Vivli hopes that the platform will make it easier for Cochrane contributors to access clinical trial data through its harmonized request process. Cochrane contributers are a core constituency of the Vivli platform - both in development and moving forward. We look forward to integrating your valuable feedback as we seek to continually improve the platform and ensure that it meets your needs.”

Find out more and let us know what you think.

May 16, 2018